Chris Nolet insider trades

Open-market stock purchases and sales by Chris Nolet, Director at ArriVent BioPharma, Inc, from SEC Form 4 filings since Jul 16, 2019.

Recent trades

DateStockTradeValue
Jun 18, 2026AVBP ArriVent BioPharma, IncBought (not open market)—

Companies traded

  • AVBP ArriVent BioPharma, Inc: other filings, last Jun 18, 2026
  • JSPR Jasper Therapeutics, Inc: other filings, last Jul 3, 2025
  • RVNC Revance Therapeutics, Inc: other filings, last Feb 6, 2025
  • PTE Polarityte, Inc: other filings, last Jan 12, 2023
  • VIE Viela Bio, Inc: other filings, last Mar 15, 2021

Get free alerts when Chris Nolet files a new trade →